Dual-responsive polypeptide nanoparticles attenuate tumor-associated stromal desmoplasia and anticancer through programmable dissociation

Biomaterials. 2022 May:284:121469. doi: 10.1016/j.biomaterials.2022.121469. Epub 2022 Mar 23.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Doxorubicin
  • Humans
  • Nanoparticles*
  • Neoplasms* / drug therapy
  • Peptides

Substances

  • Peptides
  • Doxorubicin